Stanniocalcin-1 as a Marker for Detection of Minimal Residual Disease in Patients with Acute Leukemia
Heba Mostafa Abdallah El-Maraghy;
Abstract
The term "minimal residual disease, MRD" describes a disease that is detected only by laboratory techniques more sensitive than morphology, such as flow cytometry [FCM] for immunologic MRD or polymerase chain reaction [PCR] for molecular MRD. This residua
Other data
| Title | Stanniocalcin-1 as a Marker for Detection of Minimal Residual Disease in Patients with Acute Leukemia | Other Titles | ستانيوكالسين 1 كمعلم لرصد المرض المتبقي الأقل في مرضي سرطان الدم الحاد | Authors | Heba Mostafa Abdallah El-Maraghy | Keywords | Stanniocalcin-1 as a Marker for Detection of Minimal Residual Disease in Patients with Acute Leukemia | Issue Date | 2013 | Description | The term "minimal residual disease, MRD" describes a disease that is detected only by laboratory techniques more sensitive than morphology, such as flow cytometry [FCM] for immunologic MRD or polymerase chain reaction [PCR] for molecular MRD. This residua |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 114198Final Dr. Heba El-Maraghy.pdf | 297.82 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.